HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers successfully suppressed the virus in mice and discovered a way to kill infected cells ...
In 2012, University of Melbourne immunologist Damian Purcell read a study that, he said, “blew my socks off.” Published by a physician in a remote town in Australia’s red center called Alice ...
A research team from Kumamoto University has made a new discovery that reveals how the human T-cell leukemia virus type 1 (HTLV-1) silently persists in the body. Their finding potentially lays the ...
HTLV-1 is a virus that infects a type of white blood cell called a T‐lymphocyte, or T-cell (pictured). The new study could lead to the first treatments and potential cure for the virus that impacts ...
Around 10 million people globally live with the life-threatening virus HTLV-1. Yet it remains a poorly understood disease that currently has no preventative treatments and no cure. But a landmark ...
This study shows that TGF-β triggers the nuclear translocation of HBZ specifically in ATL cells from patients with ATL, not in HTLV-1–infected cells from asymptomatic carriers. JunB interacts with HBZ ...
Around 10 million people globally live with the life-threatening human T-cell lymphotropic virus type-1 (HTLV-1), yet it remains a poorly understood disease that currently has no preventative ...
A research team from Kumamoto University has made a new discovery that reveals how the human T-cell leukemia virus type 1 (HTLV-1) silently persists in the body. Their finding potentially lays the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results